| Bioactivity | Cyclic MKEY TFA is a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, which protects against atherosclerosis and aortic aneurysm formation by mediating inflammation. Cyclic MKEY TFA also protects against stroke-induced brain injury in mice[1][2]. |
| Name | Cyclic MKEY TFA |
| Sequence | Cys-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Ser-Lys-Ser-Ser-Asn-Leu-Ala-Val-Val-Phe-Val-Thr-Arg-Cys (Disulfide bridge:Cys1-Cys22) |
| Shortening | CKEYFYTSSKSSNLAVVFVTRC (Disulfide bridge:Cys1-Cys22) |
| Formula | C115H175F3N28O36S2 |
| Molar Mass | 2644.89 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Cyclic MKEY TFA
CAS: F: C115H175F3N28O36S2 W: 2644.89
Cyclic MKEY TFA is a synthetic cyclic peptide inhibitor of CXCL4-CCL5 heterodimer formation, which protects against athe
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.